#Veterans Affairs

A Georgia veterans medical center alerted nearly 4,600 patients of possible exposure to HIV and hepatitis B and C.

In his guilty plea, the New Jersey man detailed how he conspired with others to steal HIV meds from a VA pharmacy and resell them.

A recent study of veterans found that antiretroviral treatment was not associated with a mitigated dementia risk.

A lawsuit alleges he tested HIV positive in 1995, but federal health care workers missed numerous chances to inform him.

In 2019, almost 172 million prescription drugs were sent by mail. Since COVID-19, that number has increased nearly 21%.

The Veterans Health Administration is the nation’s largest single provider of medical care to people with HIV.

An analysis of veterans seeking PrEP found that they often had to be extraordinarily persistent in their efforts to receive a prescription.

These risks include hospitalization and death.

Elsewhere in the Fiscal Year 2019 appropriations process, Congress attempts to restore order.

According to a recent study, such a disparity persists even when access to care for the virus is equal.

Known as polypharmacy, taking numerous medications has been linked to such risks in the general population as well.

Merck’s hepatitis C treatment cured almost all those with stages 3 through 5 of chronic kidney disease in a VA database.

This finding falls in line with numerous analyses that show that PrEP’s benefits are largely not reaching Black gay and bi men.

Real-world data showed Merck’s hep C regimen performed well among a population with genotypes 1 or 4 and multiple other health conditions.

The prevalence of each virus is up to three times higher among homeless versus non-homeless veterans.

A look at Proposition 61—the Drug Price Relief Act—before it goes to California voters in November.